Search research articles
Contact Us
Filters
Showing results (1-10 of 205) with videos related to
Page
of 21
Sort By:
Annals of Surgical Oncology
|
October 16, 2023
Relatlimab, an Immune Checkpoint Inhibitor that Blocks LAG-3, the Latest Drug to be Added to the Arsenal of Systemic Therapies for Melanoma: What Does a Surgical Oncologist Need to Know?
Alexander C J van Akkooi
Annals of Surgical Oncology
|
October 20, 2025
Melanoma 2.0: Time to Move Beyond Breslow Thickness?
Alexander C J van Akkooi
Melanoma Research
|
July 4, 2014
Sentinel node followed by completion lymph node dissection versus nodal observation: staging or therapeutic? Controversy continues despite final results of MSLT-1
Alexander C J van Akkooi
Melanoma Research
|
February 28, 2013
Comments and controversies: sentinel node and lymphadenectomy in melanoma: staging or therapeutical?: what to expect from the multicenter selective lymphadenectomy trial-1 results in melanoma?
Alexander C J van Akkooi
ANZ Journal of Surgery
|
June 20, 2026
Past, Present and Future: The Role of Sentinel Lymph Node Biopsy (SLNB) for Merkel Cell Carcinoma
Alexander C J van Akkooi
Current Oncology Reports
|
June 6, 2024
Management of Localized Melanoma in the Anti-PD-1 Era
Elan Novis, Alexander C J van Akkooi
Expert Review of Anticancer Therapy
|
June 18, 2025
An evaluation of nivolumab and ipilimumab for the treatment of resectable stage III melanoma
Alistair McCombe, Alexander C J van Akkooi
The Lancet. Oncology
|
March 8, 2019
The extent of surgery for stage III melanoma: how much is appropriate?
Viola Franke, Alexander C J van Akkooi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2015
Making Peace With Cancer
Christiane A Voit, Alexander C J van Akkooi
The British Journal of Surgery
|
February 9, 2022
Stage III melanoma: role of lymph node dissection and (neo-)adjuvant systemic therapies
Lisanne P Zijlker, Alexander C J van Akkooi
Page
of 21
Search research articles
Search
Showing results (1-10 of 205) with videos related to
Sort By:
Page
of 21
Annals of Surgical Oncology
|
October 16, 2023
Relatlimab, an Immune Checkpoint Inhibitor that Blocks LAG-3, the Latest Drug to be Added to the Arsenal of Systemic Therapies for Melanoma: What Does a Surgical Oncologist Need to Know?
Alexander C J van Akkooi
Annals of Surgical Oncology
|
October 20, 2025
Melanoma 2.0: Time to Move Beyond Breslow Thickness?
Alexander C J van Akkooi
Melanoma Research
|
July 4, 2014
Sentinel node followed by completion lymph node dissection versus nodal observation: staging or therapeutic? Controversy continues despite final results of MSLT-1
Alexander C J van Akkooi
Melanoma Research
|
February 28, 2013
Comments and controversies: sentinel node and lymphadenectomy in melanoma: staging or therapeutical?: what to expect from the multicenter selective lymphadenectomy trial-1 results in melanoma?
Alexander C J van Akkooi
ANZ Journal of Surgery
|
June 20, 2026
Past, Present and Future: The Role of Sentinel Lymph Node Biopsy (SLNB) for Merkel Cell Carcinoma
Alexander C J van Akkooi
Current Oncology Reports
|
June 6, 2024
Management of Localized Melanoma in the Anti-PD-1 Era
Elan Novis, Alexander C J van Akkooi
Expert Review of Anticancer Therapy
|
June 18, 2025
An evaluation of nivolumab and ipilimumab for the treatment of resectable stage III melanoma
Alistair McCombe, Alexander C J van Akkooi
The Lancet. Oncology
|
March 8, 2019
The extent of surgery for stage III melanoma: how much is appropriate?
Viola Franke, Alexander C J van Akkooi
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 14, 2015
Making Peace With Cancer
Christiane A Voit, Alexander C J van Akkooi
The British Journal of Surgery
|
February 9, 2022
Stage III melanoma: role of lymph node dissection and (neo-)adjuvant systemic therapies
Lisanne P Zijlker, Alexander C J van Akkooi
Page
of 21